Controlled gelation and degradation rates of injectable hyaluronic acid-based hydrogels through a double crosslinking strategy

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 10, 2011, Pages 790-797

  Tan, Huaping ^a   Li, Han ^a   Rubin, J Peter ^a,b,c   Marra, Kacey G ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b University of Pittsburgh   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Genipin; Hyaluronic acid; Injectable hydrogel; Schiff base; Soft tissue engineering

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABILITY; BIOMECHANICS; CONTROLLED DRUG DELIVERY; CROSSLINKING; DEGRADATION; GELATION; HYDROGELS; ORGANIC ACIDS; SCAFFOLDS (BIOLOGY); TISSUE;

BIODEGRADABLE HYDROGELS; CROSS-LINKED HYDROGELS; DEGRADATION RATE; DOUBLE CROSSLINKING; GENIPIN; INJECTABLE HYDROGELS; INJECTABLE SCAFFOLDS; INJECTABLES; SCHIFF-BASE; SOFT TISSUE ENGINEERING;

HYALURONIC ACID;

ALDEHYDE; AMINO ACID; GENIPIN; HYALURONIC ACID; POLYSACCHARIDE; SCHIFF BASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CHEMICAL REACTION; CROSS LINKING; HISTOLOGY; HYDROGEL; IN VIVO STUDY; MACROPHAGE; MALE; MORPHOLOGY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TISSUE ENGINEERING; YOUNG MODULUS;

EID: 80054758233     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.378     Document Type: Article

References (37)

1. Ameer GA, Mahmood TA, Langer R. 2002; A biodegradable composite scaffold for cell transplantation. J Orthop Res 20: 16-19.
2. Anseth KS, Metters AT, Bryant SJ, et al. 2002; In situ forming degradable networks and their application in tissue engineering and drug delivery. J Control Rel 78: 199-209.
3. Balakrishnan B, Jayakrishnan A. 2005; Self-crosslinking biopolymers as injectable in situ forming biodegradable scaffolds. Biomaterials 26: 3941-3951.
4. Bouhadir KH, Hausman DS, Mooney DJ. 1999; Synthesis of crosslinked poly(aldehyde guluronate) hydrogels. Polymer 40: 3575-3584.
5. Bouhadir KH, Kruger GM, Lee KY, et al. 2000; Sustained and controlled release of daunomycin from crosslinked poly(aldehyde guluronate) hydrogels. J Pharm Sci 89: 910-919.
6. Bulpitt P, Aeschlimann D. 1999; New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res 47: 152-169.
7. Campoccia D, Doherty P, Radice M, et al. 1998; Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 23: 2101-2127.
8. Curotto E, Aros F. 1993; Quantitative determination of chitosan and the percentage of free amino groups. Anal Biochem 211: 240-241.
9. Elisseeff J, McIntosh W, Anseth K, et al. 2000; Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks. J Biomed Mater Res 51: 164-171.
10. Fraser JR, Laurent TC, Laurent UB. 1997; Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242: 27-33.
11. Goa KL, Benfield P. 1994; Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs 47: 536-566.
12. Holland TA, Tessmar JK, Tabata Y, et al. 2004; Transforming growth factor-β1 release from oligo[poly(ethylene glycol) fumarate] hydrogels in conditions that model the cartilage wound healing environment. J Control Rel 94: 101-114.
13. Hou QP, De Bank PA, Shakesheff KM. 2004; Injectable scaffolds for tissue regeneration. J Mater Chem 14: 1915-1923.
14. Ito T, Yeo Y, Highley CB, et al. 2007; The prevention of peritoneal adhesions by in situ crosslinking hydrogels of hyaluronic acid and cellulose derivatives. Biomaterials 28: 975-983.
15. Jia X, Yeo Y, Clifton RJ, et al. 2006; Hyaluronic acid-based microgels and microgel networks for vocal fold regeneration. Biomacromolecules 7: 3336-3344.
16. Leach JB, Bivens KA, Collins CN, et al. 2004; Development of photocrosslinkable hyaluronic acid polyethylene glycol-peptide composite hydrogels for soft tissue engineering. J Biomed Mater Res 70A: 74-82.
17. Lee KY, Mooney DJ. 2001; Hydrogels for tissue engineering. Chem Rev 101: 1869-1879.
18. Maia J, Ferreira L, Carvalho R, et al. 2005; Synthesis and characterization of new injectable and degradable dextran-based hydrogels. Polymer 46: 9604-9614.
19. Masters KS, Shah DN, Walker G, et al. 2004; Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. J Biomed Mater Res 71A: 172-180.
20. Mi FL, Shyu SS, Peng CK. 2005; Characterization of ring-opening polymerization of genipin and pH-dependent crosslinking reactions between chitosan and genipin. J Polym Sci Part A: Polym Chem 43: 1985-2000.
21. Mi FL, Tan YC, Liang HC, et al. 2001; In vitro evaluation of a chitosan membrane crosslinked with genipin. J Biomater Sci Polym Ed 12: 835-850.
22. Motokawa K, Hahn SK, Nakamura T, et al. 2006; Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin. J Biomed Mater Res 78A: 459-465.
23. Nicodemus G.D, Bryant SJ. 2008; Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng 14: 149-165.
24. Nishi KK, Jayakrishnan A. 2004; Preparation and in vitro evaluation of primaquine-conjugated gum arabic microspheres. Biomacromolecules 5: 1489-1495.
25. Park YD, Tirelli N, Hubbell JA. 2003; Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks. Biomaterials 24: 893-900.
26. Ruhela D, Riviere K, Szoka FC. 2006; Efficient synthesis of an aldehyde functionalized hyaluronic acid and its application in the preparation of hyaluronan-lipid conjugates. Bioconjugate Chem 17: 1360-1363.
27. Shu XZ, Liu YC, Luo Y, et al. 2002; Disulfide crosslinked hyaluronan hydrogels. Biomacromolecules 3: 1304-1311.
28. Sung HW, Huang RN, Huang LLH, et al. 1998; Feasibility study of a natural crosslinking reagent for biological tissue fixation. J Biomed Mater Res 42: 560-567.
29. Tan H, Chu CR, Payne KA, et al. 2009; Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials 30: 2499-2506.
30. Tan H, DeFail AJ, Rubin JP, et al. 2010; Novel multiarm PEG-based hydrogels for tissue engineering. J Biomed Mater Res 92A: 979-987.
31. Tan H, Marra KG. 2010; Injectable, biodegradable hydrogels for tissue engineering applications. Materials 3: 1746-1767.
32. Tan H, Ramirez CM, Miljkovic N, et al. 2009; Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering. Biomaterials 30: 6844-6853.
33. Tememoff JS, Mikos AG. 2000; Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 21: 2405-2412.
34. Toole BP. 1990; Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol 2: 839-844.
35. Tsai CC, Huang RN, Sung HW, et al. 2000; In vitro evaluation of the genotoxicity of a naturally occurring crosslinking agent (genipin) for biologic tissue fixation. J Biomed Mater Res 52: 58-65.
36. Wieland JA, Houchin-Ray TL, Shea LD. 2007; Non-viral vector delivery from PEG-hyaluronic acid hydrogels. J Control Rel 120: 233-241.
37. Yu H, Lu J, Xiao C. 2007; Preparation and properties of novel hydrogels from oxidized Konjac glucomannan crosslinked chitosan for in vitro drug delivery. Macromol Biosci 7: 1100-1111.